These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17369059)

  • 21. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
    Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
    Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S; Tanaka T
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial.
    Genton P; Sadzot B; Fejerman N; Peltola J; Despland PA; Steinhoff B; Rektor I; Wroe S; Maubrey MC; Vandervelden C; van Hammée G; Schlit AF; van Paesschen W
    Acta Neurol Scand; 2006 Jun; 113(6):387-94. PubMed ID: 16674605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.
    Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A
    Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A long-term open-label extension study assessing cognition and behavior, tolerability, safety, and efficacy of adjunctive levetiracetam in children aged 4 to 16 years with partial-onset seizures.
    Schiemann-Delgado J; Yang H; Loge Cde L; Stalvey TJ; Jones J; Legoff D; Mintz M
    J Child Neurol; 2012 Jan; 27(1):80-9. PubMed ID: 21876066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levetiracetam extended release conversion to monotherapy for the treatment of patients with partial-onset seizures: a double-blind, randomised, multicentre, historical control study.
    Chung S; Ceja H; Gawłowicz J; Avakyan G; McShea C; Schiemann J; Lu S
    Epilepsy Res; 2012 Aug; 101(1-2):92-102. PubMed ID: 22516508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B; Schaich L
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
    Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
    Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures.
    Baulac M; Brodie MJ; Elger CE; Krakow K; Stockis A; Meyvisch P; Falter U
    Epilepsia; 2007 Mar; 48(3):589-92. PubMed ID: 17326794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
    Lambrechts DA; Sadzot B; van Paesschen W; van Leusden JA; Carpay J; Bourgeois P; Urbain E; Boon PA
    Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
    Hufnagel A; Ben-Menachem E; Gabbai AA; Falcão A; Almeida L; Soares-da-Silva P
    Epilepsy Res; 2013 Feb; 103(2-3):262-9. PubMed ID: 22871333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the initial efficacy of levetiracetam in patients with refractory epilepsy.
    Lee GH; Kim BM; Kang JK; Lee SA
    Seizure; 2013 Apr; 22(3):185-8. PubMed ID: 23280273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
    Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
    Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.